Article info
PostScript
Letter
Immunogenicity to infliximab is associated with HLA-DRB1
- Correspondence to Dr Severine Vermeire, Gastroenterology Department, University Hospitals Leuven, Herestraat 49, Leuven B-3000, Belgium; severine.vermeire{at}uzleuven.be
Citation
Immunogenicity to infliximab is associated with HLA-DRB1
Publication history
- Received March 30, 2015
- Accepted March 31, 2015
- First published April 15, 2015.
Online issue publication
July 09, 2015
Article Versions
- Previous version (15 April 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions